← All trials
NCT00371059
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2007
- Primary completion
- Jun 1, 2009
- Completion date
- Sep 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 164
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- East Kent Hospitals University NHS Foundation TrustLead sponsor
- KENT AND MEDWAY NHSOverall official - principal investigator
- University of LondonCollaborator
- Indiana UniversityCollaborator
- University of OxfordCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.